Telemedicine-mediated follow-up for advanced chronic obstructive pulmonary disease potentially improves quality of life and ...

Recent study aimed to explore the impact of verbal communication on the consciousness level, pain, and agitation of ...

Researchers at the Indiana University School of Medicine, Eskenazi Health, Regenstrief Institute and other partners have ...

Researchers at Western's Schulich School of Medicine & Dentistry and London Health Sciences Centre Research Institute (LHSCRI) have launched a ...

In a post hoc analysis of pre-diabetic patients, treatment with Aphaia’s formulation for 6 weeks improved OGTT glucose level 2h post challenge from 8.72 ± 0.81 to 6.76 ± 1.13 mmol/L (n=12, p= 0.003); ...

The FDA said Dexcom issued a correction for certain continuous glucose monitor apps due to a software design error that ...

MBX Biosciences stock surged on strong Phase 2 data for canvuparatide in hypoparathyroidism. Click here to find out why MBX ...

Delaying MTX initiation by 4 weeks after PCV13 vaccination significantly improved humoral responses in patients with RA, without compromising disease control.

EVERLAST-A Phase 2a trial enrollment ongoing with data expected 2H 2026 MENLO PARK, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology ...

Researchers at the Indiana University School of Medicine, Eskenazi Health, Regenstrief Institute and other partners have demonstrated the feasibility of conducting dementia prevention trials among ...

The science community has pushed back at the latest claims that acetaminophen (aka paracetamol) is a key factor in the ...

Ultragenyx Pharmaceutical Inc. ( NASDAQ: RARE) Bank of America Global Healthcare Conference 2025 September 23, 2025 6:35 AM ...